BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23356028)

  • 1. Drug-resistant leprosy: monitoring and current status.
    Williams DL; Gillis TP
    Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
    Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
    Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
    Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT
    Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of drug resistance in Mycobacterium leprae.
    Williams DL; Gillis TP
    Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
    Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
    Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
    Lopez-Roa RI; Fafutis-Morris M; Masanori M
    Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for effective short-course regimens for the treatment of leprosy.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
    [No Abstract]   [Full Text] [Related]  

  • 12. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
    Sapkota BR; Ranjit C; Macdonald M
    Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary multidrug-resistant leprosy, United States.
    Williams DL; Hagino T; Sharma R; Scollard D
    Emerg Infect Dis; 2013 Jan; 19(1):179-81. PubMed ID: 23260417
    [No Abstract]   [Full Text] [Related]  

  • 15. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 20. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin.
    Zhang L; Namisato M; Matsuoka M
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):468-72. PubMed ID: 15755201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.